Enalapril

Excerpt

Enalapril maleate is a prominent angiotensin-converting enzyme inhibitor approved by the US Food and Drug Administration (FDA) for the treatment of heart failure, chronic hypertension, and asymptomatic left ventricular dysfunction. The FDA has approved a fixed-dose combination of enalapril with hydrochlorothiazide. Enalapril is utilized in asymptomatic left ventricular dysfunction as it mitigates progression to symptomatic heart failure and reduces mortality.